Analysts have updated their price target for Community Healthcare Trust, maintaining it at $17.90. Slight adjustments to growth projections and discount rates balance each other out in their assessment of the company’s valuation outlook.
What's in the News
- The Board of Directors increased the common stock cash dividend for the quarter ended September 30, 2025. The dividend is now $0.475 per share, bringing the annualized dividend to $1.90 per share (Key Developments).
- The next dividend is payable on November 21, 2025, to shareholders of record on November 7, 2025 (Key Developments).
- Community Healthcare Trust has consistently increased its dividend every quarter since its Initial Public Offering (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at $17.90 per share.
- Discount Rate has fallen slightly from 9.30% to 9.18%.
- Revenue Growth projection has risen slightly from 9.13% to 9.23%.
- Net Profit Margin has decreased modestly from 13.30% to 12.77%.
- Future P/E ratio has declined significantly, changing from 38.47x to 31.62x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.